NewsRx

Search our medical news database

Chronic Lymphocytic Leukemia

The Leukemia & Lymphoma Society Offers Program on Chronic Lymphocytic Leukemia

Published in Blood Weekly, July 12th, 2007

John Byrd, M.D., an expert on leukemia, will discuss novel treatment approaches for chronic lymphocytic leukemia (CLL) in a free telephone workshop entitled Current Progress in CLL Therapy and Clinical Trials. The program is scheduled for Tuesday, Jun. 26, 2007, 1:00 p.m. - 2:00 p.m. ET.

The program is being offered by The Leukemia & Lymphoma Society, the leading source of information and support for patients battling leukemia, lymphoma and myeloma, and is supported by an unrestricted educational grant from Cephalon Oncology and Biogen Idec.

Dr. Byrd is an associate professor of Internal Medicine and director of Hematologic Malignancy at Ohio State...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook